Enzalutamide in European and North American men participating in the AFFIRM trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|115|1|41-49

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.115, Iss.1, 2015-01, pp. : 41-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SOP 06: Selecting the Participating Centers and Activation of a Trial

By  

Oncology Research and Treatment, Vol. 26, Iss. 6, 2004-11 ,pp. : 34-35

Karger

Access to resources Recommend Favorite

Comparing sequencing of abiraterone and enzalutamide in men with metastatic castration‐resistant prostate cancer: A retrospective study

By  

THE PROSTATE, Vol. 78, Iss. 4, 2018-03 ,pp. : 278-278

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of enzalutamide in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel: Expanded access in North America

By  

THE PROSTATE, Vol. 75, Iss. 8, 2015-06 ,pp. : 836-844

John Wiley & Sons Inc

Access to resources Recommend Favorite

New Insights into Extended Prophylaxis after Orthopaedic Surgery – the North American Fragmin Trial Experience

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 95-100

Karger

Access to resources Recommend Favorite

Predictors of Adherence to Supervised Exercise in Lymphoma Patients Participating in a Randomized Controlled Trial

By Courneya Kerry  

Annals of Behavioral Medicine, Vol. 40, Iss. 1, 2010-08 ,pp. : 30-39

Springer Publishing Company

Access to resources Recommend Favorite